5TH2
Cetuximab Fab in complex with L5Q meditope variant
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SSRL BEAMLINE BL12-2 |
| Synchrotron site | SSRL |
| Beamline | BL12-2 |
| Temperature [K] | 100 |
| Detector technology | IMAGE PLATE |
| Collection date | 2015-02-05 |
| Detector | RIGAKU RAXIS IV++ |
| Wavelength(s) | 1.0000 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 64.190, 83.120, 212.560 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 44.770 - 1.840 |
| R-factor | 0.1624 |
| Rwork | 0.161 |
| R-free | 0.18440 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 4gw1 |
| RMSD bond length | 0.006 |
| RMSD bond angle | 0.873 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | MOLREP |
| Refinement software | PHENIX (1.10_2155) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 44.770 | 1.890 |
| High resolution limit [Å] | 1.840 | 1.840 |
| Rmerge | 0.060 | 0.787 |
| Number of reflections | 91890 | |
| <I/σ(I)> | 15 | |
| Completeness [%] | 92.3 | 94.6 |
| Redundancy | 3.5 | 3.3 |
| CC(1/2) | 0.999 | 0.677 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1 M citric acid, 0.1 M Na2HPO4, 0.4 M K2HPO4, 1.6 M NaH2PO4 |






